These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20554322)

  • 1. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
    Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
    Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
    Raza S; Ullah K; Ahmed P; Khan B
    J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
    Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
    Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
    Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
    Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
    Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ
    Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines.
    Jácomo RH; Melo RA; Souto FR; de Mattos ER; de Oliveira CT; Fagundes EM; Bittencourt HN; Bittencourt RI; Bortolheiro TC; Paton EJ; Bendlin R; Ismael S; Chauffaille Mde L; Silva D; Pagnano KB; Ribeiro R; Rego EM
    Haematologica; 2007 Oct; 92(10):1431-2. PubMed ID: 18024380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
    Dombret H; Scrobohaci ML; Daniel MT; Micléa JM; Castaigne S; Chomienne C; Fenaux P; Degos L
    Leukemia; 1995 Jan; 9(1):19-24. PubMed ID: 7531260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
    Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L
    J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.